-
Mashup Score: 1Ibrahim Halil Sahin: A common question I received after my tweet on the PEGASUS trial... - Oncodaily | Oncology News, Insights, Stories - 4 month(s) ago
Source: Ibrahim Halil Sahin/X
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Results from a systematic review highlighted the clinical need for specific biomarkers for PAD and the viability of noninvasive ophthalmic imaging techniques for diagnosis.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
We discovered a threshold for reduced BALF CCSP to discriminate future CLAD risk; supporting the utility of BALF CCSP as a tool for early posttransplant risk stratification. Additionally, our finding that low CCSP associates with future CLAD underscores a role for club cell injury in CLAD pathobiolo …
Source: pubmed.ncbi.nlm.nih.govCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Three decades of progress in nasopharyngeal cancer - 5 month(s) ago
Tailored management for high-risk locoregional disease, with more effective immunotherapy combinations are key areas
Source: dailyreporter.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Steering Committee - 6 month(s) ago
SELECT DISEASE STATE TO EXPLORE To bring key stakeholders (HCPs, pharmaceutical and biotech companies, associations and advocacy groups) together for the common purpose of providing accurate and relevant information to the broader oncology community about the importance of testing and biomarker identification, and how to utilize biomarker status to inform treatment decisions. To emphasize the importance of biomarker testing, comprehensive genomic profiling, and identification of actionable targets across
Source: www.onclive.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Ellipsis Health and Augmedix to Partner to Bring Automated Mental Health Screenings to Patient Visits - 6 month(s) ago
/PRNewswire/ — Ellipsis Health, the market leader in AI-generated vocal biomarker technology for the identification and monitoring of mental health conditions…
Source: www.prnewswire.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0The Biomarker Toolkit — an evidence-based guideline to predict cancer biomarker success and guide development - BMC Medicine - 6 month(s) ago
Background An increased number of resources are allocated on cancer biomarker discovery, but very few of these biomarkers are clinically adopted. To bridge the gap between Biomarker discovery and clinical use, we aim to generate the Biomarker Toolkit, a tool designed to identify clinically promising biomarkers and promote successful biomarker translation. Methods All features associated with a clinically useful biomarker were identified using mixed-methodology, including systematic literature search, semi-structured interviews, and an online two-stage Delphi-Survey. Validation of the checklist was achieved by independent systematic literature searches using keywords/subheadings related to clinically and non-clinically utilised breast and colorectal cancer biomarkers. Composite aggregated scores were generated for each selected publication based on the presence/absence of an attribute listed in the Biomarker Toolkit checklist. Results Systematic literature search identified 129 attribut
Source: bmcmedicine.biomedcentral.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 1
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The lack of reliable biomarkers of testicular germ cell tumors (GCT) has posed a challenge in identifying early signs of #relapse. However, new studies suggest that plasma miR371 may be a reliable #biomarker in advanced non-teratoma #GCT. https://t.co/gub4AhrG44 #TesticularCancer https://t.co/d3EEosF48t
-
-
Mashup Score: 1Newly Published Data on a Response Biomarker for Dovitinib in Patients With RCC - The ASCO Post - 7 month(s) ago
A new report published by Knudsen et al in PLOS ONE focused on the clinical validation of a drug response predictor (DRP) biomarker algorithm for dovitinib, a receptor tyrosine kinase inhibitor of VEGFR1–3, PDGFR, FGFR1/3, c-KIT, FLT3, and topoisomerase 1 and 2. Data showed that the DRP-dovitinib tool was able to identify a subgroup of patients with advanced renal cell carcinoma (RCC) with improved clinical benefit from dovitinib treatment compared with unselected patients. “This is the first validated
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Novel Biomarker Panel Accurately Predicts Prostate Cancer Outcomes - 7 month(s) ago
New biomarker technology shows promising results for predicting the prognosis of patients with prostate cancer after radical prostatectomy.
Source: www.ajmc.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
RT @oncodaily: A common question I received after my tweet on the PEGASUS trial... - @IbrahimSahinMD1 https://t.co/9Js8Pkm449 #Biomarker #…